{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:23:13Z","timestamp":1792815793361,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T00:00:00Z","timestamp":1551052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12974-019-1436-1","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T02:02:48Z","timestamp":1551060168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Astrocytic ceramide as possible indicator of neuroinflammation"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4672-8027","authenticated-orcid":false,"given":"Nienke M.","family":"de Wit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"den Hoedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Martinez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke J.","family":"Rozemuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique T.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga E.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,25]]},"reference":[{"key":"1436_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neuroscience.2014.03.045","volume":"269","author":"GG Kovacs","year":"2014","unstructured":"Kovacs GG, Adle-Biassette H, Milenkovic I, Cipriani S, van Scheppingen J, Aronica E. Linking pathways in the developing and aging brain with neurodegeneration. Neuroscience. 2014;269:152\u201372.","journal-title":"Neuroscience."},{"issue":"6301","key":"1436_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. How neuroinflammation contributes to neurodegeneration. Science. 2016;353(6301):777\u201383.","journal-title":"Science"},{"key":"1436_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pneurobio.2015.05.002","volume":"131","author":"R Lardenoije","year":"2015","unstructured":"Lardenoije R, Iatrou A, Kenis G, Kompotis K, Steinbusch HW, Mastroeni D, et al. The epigenetics of aging and neurodegeneration. Prog Neurobiol. 2015;131:21\u201364.","journal-title":"Prog Neurobiol"},{"issue":"3","key":"1436_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11910-017-0733-2","volume":"17","author":"M Schain","year":"2017","unstructured":"Schain M, Kreisl WC. Neuroinflammation in neurodegenerative disorders\u2014a review. Curr Neurol Neurosci Rep. 2017;17(3):25.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"1436_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.neuron.2013.04.005","volume":"78","author":"A Lampron","year":"2013","unstructured":"Lampron A, Elali A, Rivest S. Innate immunity in the CNS: redefining the relationship between the CNS and its environment. Neuron. 2013;78(2):214\u201332.","journal-title":"Neuron."},{"issue":"3","key":"1436_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/cdd.2008.172","volume":"16","author":"JJ Rodriguez","year":"2009","unstructured":"Rodriguez JJ, Olabarria M, Chvatal A, Verkhratsky A. Astroglia in dementia and Alzheimer\u2019s disease. Cell Death Differ. 2009;16(3):378\u201385.","journal-title":"Cell Death Differ"},{"issue":"1","key":"1436_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1212\/WNL.55.1.132","volume":"55","author":"IR Mackenzie","year":"2000","unstructured":"Mackenzie IR. Activated microglia in dementia with Lewy bodies. Neurology. 2000;55(1):132\u20134.","journal-title":"Neurology."},{"issue":"11","key":"1436_CR8","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1172\/JCI63113","volume":"122","author":"LH Martens","year":"2012","unstructured":"Martens LH, Zhang J, Barmada SJ, Zhou P, Kamiya S, Sun B, et al. Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. J Clin Invest. 2012;122(11):3955\u20139.","journal-title":"J Clin Invest"},{"key":"1436_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.expneurol.2018.01.016","volume":"302","author":"M Ren","year":"2018","unstructured":"Ren M, Guo Y, Wei X, Yan S, Qin Y, Zhang X, et al. TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson\u2019s disease. Exp Neurol. 2018;302:205\u201313.","journal-title":"Exp Neurol"},{"key":"1436_CR10","doi-asserted-by":"crossref","unstructured":"Ardura-Fabregat A, EWGM B, Boza-Serrano A, Brioschi S, Castro-Gomez S, Ceyz\u00e9riat K, et al. Targeting neuroinflammation to treat Alzheimer\u2019s disease. CNS Drugs. 2017;31:1057\u201382.","DOI":"10.1007\/s40263-017-0483-3"},{"key":"1436_CR11","doi-asserted-by":"crossref","unstructured":"Coll RC, Robertson AAB, Chae JJ, Higgins SC, Mu\u00f1oz-Planillo R, Inserra MC, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;","DOI":"10.1038\/nm.3806"},{"issue":"7","key":"1436_CR12","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2004;101(7):2070\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1436_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073094","volume":"8","author":"MM Mielke","year":"2013","unstructured":"Mielke MM, Maetzler W, Haughey NJ, Bandaru VV, Savica R, Deuschle C, et al. Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson\u2019s disease and associated with cognitive impairment: a pilot study. PLoS One. 2013;8(9):e73094.","journal-title":"PLoS One"},{"key":"1436_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jns.2016.09.028","volume":"370","author":"Y Xing","year":"2016","unstructured":"Xing Y, Tang Y, Zhao L, Wang Q, Qin W, Ji X, et al. Associations between plasma ceramides and cognitive and neuropsychiatric manifestations in Parkinson\u2019s disease dementia. J Neurol Sci. 2016;370:82\u20137.","journal-title":"J Neurol Sci"},{"key":"1436_CR15","doi-asserted-by":"crossref","unstructured":"Martinez PM, Mielke MM. Sphingolipids in Alzheimer\u2019s disease and related disorders. J Alzheimers Dis. 2017;60:753\u20136.","DOI":"10.3233\/JAD-170735"},{"issue":"12","key":"1436_CR16","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.bbamem.2006.06.009","volume":"1758","author":"G Echten-Deckert van","year":"2006","unstructured":"van Echten-Deckert G, Herget T. Sphingolipid metabolism in neural cells. Biochim Biophys Acta. 2006;1758(12):1978\u201394.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"1436_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s12325-016-0474-7","volume":"34","author":"R Gualtierotti","year":"2017","unstructured":"Gualtierotti R, Guarnaccia L, Beretta M, Navone SE, Campanella R, Riboni L, et al. Modulation of neuroinflammation in the central nervous system: role of chemokines and sphingolipids. Adv Ther. 2017;34(2):396\u2013420.","journal-title":"Adv Ther"},{"issue":"2\u20133","key":"1436_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1388-1981(02)00341-4","volume":"1585","author":"M Maceyka","year":"2002","unstructured":"Maceyka M, Payne SG, Milstien S, Spiegel S. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta. 2002;1585(2\u20133):193\u2013201.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1436_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1083\/jcb.200307017","volume":"164","author":"JT Lee","year":"2004","unstructured":"Lee JT, Xu J, Lee JM, Ku G, Han X, Yang DI, et al. Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol. 2004;164(1):123\u201331.","journal-title":"J Cell Biol"},{"issue":"1","key":"1436_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pharmthera.2006.04.004","volume":"112","author":"M Alwani El","year":"2006","unstructured":"El Alwani M, Wu BX, Obeid LM, Hannun YA. Bioactive sphingolipids in the modulation of the inflammatory response. Pharmacol Ther. 2006;112(1):171\u201383.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"1436_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00018-012-1038-x","volume":"70","author":"C Mencarelli","year":"2013","unstructured":"Mencarelli C, Martinez-Martinez P. Ceramide function in the brain: when a slight tilt is enough. Cell Mol Life Sci. 2013;70(2):181\u2013203.","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"1436_CR22","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.3681","volume":"20","author":"L Mayo","year":"2014","unstructured":"Mayo L, Trauger SA, Blain M, Nadeau M, Patel B, Alvarez JI, et al. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat Med. 2014;20(10):1147\u201356.","journal-title":"Nat Med"},{"key":"1436_CR23","doi-asserted-by":"crossref","unstructured":"Kitatani K, Idkowiak-Baldys J, Hannun YA. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal. 2008;20:1010\u20138.","DOI":"10.1016\/j.cellsig.2007.12.006"},{"key":"1436_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/4-431-34200-1_12","volume-title":"Sphingolipid Biology","author":"Y Zeidan","year":"2006","unstructured":"Zeidan Y, Marchesini N, Hannun YA. Overview of acid and neutral sphingomyelinases in cell signaling. In: Sphingolipid Biology; 2006. p. 167\u201381."},{"issue":"6","key":"1436_CR25","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.cellsig.2009.01.026","volume":"21","author":"RW Jenkins","year":"2009","unstructured":"Jenkins RW, Canals D, Hannun YA. Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell Signal. 2009;21(6):836\u201346.","journal-title":"Cell Signal"},{"issue":"11","key":"1436_CR26","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/BF02531119","volume":"5","author":"KA Karlsson","year":"1970","unstructured":"Karlsson KA. Sphingolipid long chain bases. Lipids. 1970;5(11):878\u201391.","journal-title":"Lipids."},{"key":"1436_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0076-6879(07)32004-1","volume":"432","author":"MC Sullards","year":"2007","unstructured":"Sullards MC, Allegood JC, Kelly S, Wang E, Haynes CA, Park H, et al. Structure-specific, quantitative methods for analysis of sphingolipids by liquid chromatography-tandem mass spectrometry: \u201cinside-out\u201d sphingolipidomics. Methods Enzym. 2007;432:83\u2013115.","journal-title":"Methods Enzym"},{"issue":"4","key":"1436_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s12017-010-8114-x","volume":"12","author":"O Ben-David","year":"2010","unstructured":"Ben-David O, Futerman AH. The role of the ceramide acyl chain length in neurodegeneration: involvement of ceramide synthases. NeuroMolecular Med. 2010;12(4):341\u201350.","journal-title":"NeuroMolecular Med"},{"key":"1436_CR29","doi-asserted-by":"crossref","unstructured":"Son JH, Yoo HH, Kim DH. Activation of de novo synthetic pathway of ceramides is responsible for the initiation of hydrogen peroxide-induced apoptosis in HI-60 cells. J Toxicol Environ Health Part A. 2007:1310\u20138.","DOI":"10.1080\/15287390701434364"},{"issue":"1","key":"1436_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1083\/jcb.150.1.155","volume":"150","author":"AD Tepper","year":"2000","unstructured":"Tepper AD, Ruurs P, Wiedmer T, Sims PJ, Borst J, Van Blitterswijk WJ. Sphingomyelin hydrolysis to ceramide during the execution phase of apoptosis results from phospholipid scrambling and alters cell-surface morphology. J Cell Biol. 2000;150(1):155\u201364.","journal-title":"J Cell Biol"},{"key":"1436_CR31","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1096\/fj.00-0122com","volume":"14","author":"C Bl\u00e1zquez","year":"2000","unstructured":"Bl\u00e1zquez C, Galve-Roperh I, Guzm\u00e1n M. De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase. FASEB J. 2000;14:2315\u201322.","journal-title":"FASEB J"},{"issue":"3","key":"1436_CR32","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3233\/JAD-160551","volume":"60","author":"NM Wit de","year":"2017","unstructured":"de Wit NM, Snkhchyan H, den Hoedt S, Wattimena D, de Vos R, Mulder MT, et al. Altered sphingolipid balance in capillary cerebral amyloid Angiopathy. J Alzheimers Dis. 2017;60(3):795\u2013807.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1436_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-012-1014-4","volume":"124","author":"R Doorn Van","year":"2012","unstructured":"Van Doorn R, Nijland PG, Dekker N, Witte ME, Lopes-Pinheiro MA, Van Het Hof B, et al. Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes. Acta Neuropathol. 2012;124(3):397\u2013410.","journal-title":"Acta Neuropathol"},{"issue":"7","key":"1436_CR34","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/eci.12643","volume":"46","author":"J Versmissen","year":"2016","unstructured":"Versmissen J, Vongpromek R, Yahya R, van der Net JB, van Vark-van der Zee L, Blommesteijn-Touw J, et al. Familial hypercholesterolaemia: cholesterol efflux and coronary disease. Eur J Clin Investig. 2016;46(7):643\u201350.","journal-title":"Eur J Clin Investig"},{"issue":"8","key":"1436_CR35","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/o59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37(8):911\u20137.","journal-title":"Can J Biochem Physiol"},{"issue":"3","key":"1436_CR36","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.neuroscience.2004.08.056","volume":"130","author":"H Satoi","year":"2005","unstructured":"Satoi H, Tomimoto H, Ohtani R, Kitano T, Kondo T, Watanabe M, et al. Astroglial expression of ceramide in Alzheimer\u2019s disease brains: a role during neuronal apoptosis. Neuroscience. 2005;130(3):657\u201366.","journal-title":"Neuroscience."},{"key":"1436_CR37","doi-asserted-by":"crossref","unstructured":"Hannun YA, Obeid LM. Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol. 2018;19:175\u201391.","DOI":"10.1038\/nrm.2017.107"},{"key":"1436_CR38","doi-asserted-by":"crossref","unstructured":"Jiang Z, Li F, Wan Y, Han Z, Cao L, Deng Y, et al. LASS5 interacts with SDHB and synergistically represses p53 and p21 activity. Curr Mol Med. 2016;","DOI":"10.2174\/1566524016666160607090012"},{"key":"1436_CR39","doi-asserted-by":"crossref","unstructured":"Gu LZ, Huang BS, Shen W, Gao L, Ding ZZ, Wu HW, et al. Early activation of nSMase2\/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi. J Neuroinflammation. 2013;10","DOI":"10.1186\/1742-2094-10-109"},{"issue":"9","key":"1436_CR40","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.cellsig.2010.04.006","volume":"22","author":"J Mesicek","year":"2010","unstructured":"Mesicek J, Lee H, Feldman T, Jiang X, Skobeleva A, Berdyshev EV, et al. Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells. Cell Signal. 2010;22(9):1300\u20137.","journal-title":"Cell Signal"},{"issue":"13","key":"1436_CR41","doi-asserted-by":"publisher","first-page":"6989","DOI":"10.1074\/jbc.M115.691212","volume":"291","author":"D Gosejacob","year":"2016","unstructured":"Gosejacob D, J\u00e4ger PS, Vom Dorp K, Frejno M, Carstensen AC, K\u00f6hnke M, et al. Ceramide synthase 5 is essential to maintain C16:0-ceramide pools and contributes to the development of diet-induced obesity. J Biol Chem. 2016;291(13):6989\u20137003.","journal-title":"J Biol Chem"},{"issue":"3","key":"1436_CR42","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3233\/JAD-160739","volume":"60","author":"S Hoedt Den","year":"2017","unstructured":"Den Hoedt S, Janssen CIF, Astarita G, Piomelli D, Leijten FPJ, Crivelli SM, et al. Pleiotropic effect of human ApoE4 on cerebral ceramide and saturated fatty acid levels. J Alzheimers Dis. 2017;60(3):769\u201381.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"1436_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002063","volume":"7","author":"L Zhao","year":"2011","unstructured":"Zhao L, Spassieva SD, Jucius TJ, Shultz LD, Shick HE, Macklin WB, et al. A deficiency of ceramide biosynthesis causes cerebellar purkinje cell neurodegeneration and lipofuscin accumulation. PLoS Genet. 2011;7(5):e1002063.","journal-title":"PLoS Genet"},{"issue":"4","key":"1436_CR44","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/mds.25729","volume":"29","author":"SK Abbott","year":"2014","unstructured":"Abbott SK, Li H, Mu\u00f1oz SS, Knoch B, Batterham M, Murphy KE, et al. Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson\u2019s disease. Mov Disord. 2014;29(4):518\u201326.","journal-title":"Mov Disord"},{"key":"1436_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neurobiolaging.2016.03.027","volume":"43","author":"TA Couttas","year":"2016","unstructured":"Couttas TA, Kain N, Suchowerska AK, Quek LE, Turner N, Fath T, et al. Loss of ceramide synthase 2 activity, necessary for myelin biosynthesis, precedes tau pathology in the cortical pathogenesis of Alzheimer\u2019s disease. Neurobiol Aging. 2016;43:89\u2013100.","journal-title":"Neurobiol Aging"},{"key":"1436_CR46","doi-asserted-by":"crossref","unstructured":"Levy M, Futerman AH. Mammalian ceramide synthases. IUBMB Life. 2010;62:347\u201356.","DOI":"10.1002\/iub.319"},{"issue":"1","key":"1436_CR47","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/pros.10275","volume":"57","author":"M Eto","year":"2003","unstructured":"Eto M, Bennouna J, Hunter OC, Hershberger PA, Kanto T, Johnson CS, et al. C16 ceramide accumulates following androgen ablation in LNCaP prostate cancer cells. Prostate. 2003;57(1):66\u201379.","journal-title":"Prostate."},{"issue":"30","key":"1436_CR48","doi-asserted-by":"publisher","first-page":"27879","DOI":"10.1074\/jbc.M503002200","volume":"280","author":"Y Osawa","year":"2005","unstructured":"Osawa Y, Uchinami H, Bielawski J, Schwabe RF, Hannun YA, Brenner DA. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha. J Biol Chem. 2005;280(30):27879\u201387.","journal-title":"J Biol Chem"},{"issue":"17","key":"1436_CR49","doi-asserted-by":"publisher","first-page":"14723","DOI":"10.1074\/jbc.M210756200","volume":"278","author":"BJ Kroesen","year":"2003","unstructured":"Kroesen BJ, Jacobs S, Pettus BJ, Sietsma H, Kok JW, Hannun YA, et al. BcR-induced apoptosis involves differential regulation of C16 and C24-ceramide formation and sphingolipid-dependent activation of the proteasome. J Biol Chem. 2003;278(17):14723\u201331.","journal-title":"J Biol Chem"},{"issue":"4","key":"1436_CR50","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.biocel.2011.12.019","volume":"44","author":"D Hartmann","year":"2012","unstructured":"Hartmann D, Lucks J, Fuchs S, Schiffmann S, Schreiber Y, Ferreir\u00f3s N, et al. Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth. Int J Biochem Cell Biol. 2012;44(4):620\u20138.","journal-title":"Int J Biochem Cell Biol"},{"issue":"7","key":"1436_CR51","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.bbalip.2012.04.008","volume":"1821","author":"T Sassa","year":"2012","unstructured":"Sassa T, Suto S, Okayasu Y, Kihara A. A shift in sphingolipid composition from C24 to C16 increases susceptibility to apoptosis in HeLa cells. Biochim Biophys Acta - Mol Cell Biol Lipids. 2012;1821(7):1031\u20137.","journal-title":"Biochim Biophys Acta - Mol Cell Biol Lipids"},{"key":"1436_CR52","doi-asserted-by":"crossref","unstructured":"Mayo L, Trauger SA, Blain M, Nadeau M, Patel B, Alvarez JI, et al. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat Med. 2014;","DOI":"10.1038\/nm.3681"},{"issue":"25","key":"1436_CR53","doi-asserted-by":"publisher","first-page":"21384","DOI":"10.1074\/jbc.M112.340513","volume":"287","author":"G Wang","year":"2012","unstructured":"Wang G, Dinkins M, He Q, Zhu G, Poirier C, Campbell A, et al. Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem. 2012;287(25):21384\u201395.","journal-title":"J Biol Chem"},{"issue":"5867","key":"1436_CR54","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1126\/science.1153124","volume":"319","author":"K Trajkovic","year":"2008","unstructured":"Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319(5867):1244\u20137.","journal-title":"Science"},{"issue":"1","key":"1436_CR55","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12974-017-0882-x","volume":"14","author":"SS Dusaban","year":"2017","unstructured":"Dusaban SS, Chun J, Rosen H, Purcell NH, Brown JH. Sphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes. J Neuroinflammation. 2017;14(1):111.","journal-title":"J Neuroinflammation"},{"key":"1436_CR56","doi-asserted-by":"crossref","unstructured":"Fischer I, Alliod C, Martinier N, Newcombe J, Brana C, Pouly S. Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions. PLoS One. 2011;","DOI":"10.1371\/journal.pone.0023905"},{"issue":"8","key":"1436_CR57","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1093\/brain\/awu139","volume":"137","author":"OG Vidaurre","year":"2014","unstructured":"Vidaurre OG, Haines JD, Katz Sand I, Adula KP, Huynh JL, Mcgraw CA, et al. Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics. Brain. 2014;137(8):2271\u201386.","journal-title":"Brain"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1436-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-019-1436-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1436-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T19:09:49Z","timestamp":1582571389000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-019-1436-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,25]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1436"],"URL":"https:\/\/doi.org\/10.1186\/s12974-019-1436-1","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,25]]},"assertion":[{"value":"21 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"See materials and methods section \u2018Post-mortem human brain tissue\u2019.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"48"}}